Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa A Morais

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|June 5, 2024
Reduced penetrance of Parkinson's disease modelsVanessa A Morais, Melissa Vos
Biochemical and Biophysical Research Communications|June 26, 2017
Mitochondrial quality control pathways: PINK1 acts as a gatekeeperElvira P Leites, Vanessa A Morais
STAR Protocols|January 11, 2024
Protocol for the isolation and culture of microglia, astrocytes, and neurons from the same mouse brainElvira P Leites, Vanessa A Morais
Journal of Alzheimer'S Disease : JAD|May 14, 2010
Mitochondria dysfunction and neurodegenerative disorders: cause or consequenceVanessa A Morais, Bart De Strooper
International Journal of Molecular Sciences|April 12, 2022
Synapses: The Brain's Energy-Demanding SitesAndreia Faria-Pereira, Vanessa A Morais
STAR Protocols|February 1, 2024
Protocol for the isolation and culture of microglia, astrocytes, and neurons from the same mouse brainElvira P Leites, Vanessa A Morais
Oncoscience|March 15, 2016
PINK1, cancer and neurodegenerationCiara H O'Flanagan, Vanessa A Morais, Cora O'Neill
Journal of Cell Science|May 16, 2007
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseasesWim Mandemakers, Vanessa A Morais, Bart De Strooper
Biochemical Society Transactions|April 8, 2015
PINK1 activation-turning on a promiscuous kinaseLiesbeth Aerts, Bart De Strooper, Vanessa A Morais
Biochimica Et Biophysica Acta|January 16, 2003
N-glycosylation of recombinant human fucosyltransferase III is required for its in vivo folding in mammalian and insect cellsVanessa A Morais, Maria T Costa, Júlia Costa
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|June 5, 2024
Reduced penetrance of Parkinson's disease modelsVanessa A Morais, Melissa Vos
Biochemical and Biophysical Research Communications|June 26, 2017
Mitochondrial quality control pathways: PINK1 acts as a gatekeeperElvira P Leites, Vanessa A Morais
STAR Protocols|January 11, 2024
Protocol for the isolation and culture of microglia, astrocytes, and neurons from the same mouse brainElvira P Leites, Vanessa A Morais
Journal of Alzheimer'S Disease : JAD|May 14, 2010
Mitochondria dysfunction and neurodegenerative disorders: cause or consequenceVanessa A Morais, Bart De Strooper
International Journal of Molecular Sciences|April 12, 2022
Synapses: The Brain's Energy-Demanding SitesAndreia Faria-Pereira, Vanessa A Morais
STAR Protocols|February 1, 2024
Protocol for the isolation and culture of microglia, astrocytes, and neurons from the same mouse brainElvira P Leites, Vanessa A Morais
Oncoscience|March 15, 2016
PINK1, cancer and neurodegenerationCiara H O'Flanagan, Vanessa A Morais, Cora O'Neill
Journal of Cell Science|May 16, 2007
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseasesWim Mandemakers, Vanessa A Morais, Bart De Strooper
Biochemical Society Transactions|April 8, 2015
PINK1 activation-turning on a promiscuous kinaseLiesbeth Aerts, Bart De Strooper, Vanessa A Morais
Biochimica Et Biophysica Acta|January 16, 2003
N-glycosylation of recombinant human fucosyltransferase III is required for its in vivo folding in mammalian and insect cellsVanessa A Morais, Maria T Costa, Júlia Costa
Pageof 5